Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data
Authors:
- Sorel MuresanSMSorel Muresan
- Plamen PetrovPPPlamen Petrov
- Christopher SouthanCSChristopher Southan
- Magnus J. KjellbergMKMagnus J. Kjellberg
- Thierry KogejTKThierry Kogej
- Christian TyrchanCTChristian Tyrchan
- Peter VarkonyiPVPeter Varkonyi
- Paul Hongxing XiePXPaul Hongxing Xie
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 16 (23-24) , 1019-1030
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Analysis of in vitrobioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffoldsJournal of Cheminformatics, 2011
- Impact of high-throughput screening in biomedical researchNature Reviews Drug Discovery, 2011
- Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compoundsJournal of Cheminformatics, 2009
- A perspective of publicly accessible/open-access chemistry databasesDrug Discovery Today, 2008
- Structural Diversity of Organic Chemistry. A Scaffold Analysis of the CAS RegistryThe Journal of Organic Chemistry, 2008
- Advanced Biological and Chemical Discovery (ABCD): Centralizing Discovery Knowledge in an Inherently Decentralized WorldJournal of Chemical Information and Modeling, 2007
- Complementarity Between Public and Commercial Databases: New Opportunities in Medicinal Chemistry InformaticsCurrent Topics in Medicinal Chemistry, 2007
- Global mapping of pharmacological spaceNature Biotechnology, 2006
- Has the yo‐yo stopped? An assessment of human protein‐coding gene numberProteomics, 2004
- Combinatorial compound libraries for drug discovery: an ongoing challengeNature Reviews Drug Discovery, 2003